Urogen Pharma Ltd (URGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | URGN | AMGN | GILD | BIIB | CELG |
| Company | Urogen Pharma Ltd | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 13.97 | 265.72 | 65.50 | 201.22 | 108.01 |
| High | 14.32 | 271.68 | 66.35 | 209.64 | 108.59 |
| Low | 13.69 | 265.72 | 64.63 | 199.10 | 107.27 |
| Last | 14.04 | 270.75 | 65.61 | 209.28 | 108.24 |
| Change | +0.22 | +1.37 | +0.34 | +6.82 | +0.11 |
| % Change | +1.59% | +0.51% | +0.52% | +3.37% | +0.10% |
| Volume | 58,733 | 687,982 | 7,175,923 | 923,609 | 191,230,496 |
| 20-Day Average Volume | 296,034 | 2,066,926 | 6,773,638 | 1,227,536 | 16,188,930 |
| Previous Close | 13.82 | 269.38 | 65.27 | 202.46 | 108.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 13.99 | 269.99 | 68.30 | 201.14 | 108.17 |
| 20-Day Raw Stochastic | 51.60% | 40.81% | 9.84% | 74.86% | 63.25% |
| 20-Day Relative Strength | 44.67% | 45.67% | 29.53% | 49.94% | 64.69% |
| Weighted Alpha | -36.55 | +9.55 | -23.40 | -31.55 | +46.30 |
| Today's Opinion | 40% Sell | 56% Sell | 100% Sell | 88% Sell | 100% Buy |
| Previous Opinion | 40% Sell | 72% Sell | 100% Sell | 88% Sell | 100% Buy |
| Last Month's Opinion | 8% Buy | 40% Buy | 88% Sell | 100% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.86% since 04/19/24 | +0.46% since 04/19/24 | -1.92% since 04/19/24 | +7.57% since 04/19/24 | -1.97% since 11/13/19 |
| Low | 13.58 on 04/22/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 192.75 on 04/23/24 | 107.27 on 11/20/19 |
| High | 14.85 on 04/23/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 209.46 on 04/26/24 | 110.53 on 11/14/19 |
| 1-Month | |||||
| %Chg | -7.81% since 03/26/24 | -4.12% since 03/26/24 | -9.58% since 03/26/24 | -1.38% since 03/26/24 | +5.14% since 10/18/19 |
| Low | 12.37 on 04/11/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 189.44 on 04/19/24 | 102.40 on 10/21/19 |
| High | 15.67 on 03/27/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 217.57 on 03/28/24 | 110.70 on 11/13/19 |
| 3-Month | |||||
| %Chg | -12.97% since 01/26/24 | -13.35% since 01/26/24 | -17.66% since 01/26/24 | -14.59% since 01/26/24 | +13.63% since 08/20/19 |
| Low | 12.37 on 04/11/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 189.44 on 04/19/24 | 93.41 on 08/23/19 |
| High | 19.87 on 02/16/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 251.99 on 01/31/24 | 110.70 on 11/13/19 |
| 6-Month | |||||
| %Chg | +25.09% since 10/26/23 | +0.17% since 10/26/23 | -16.59% since 10/26/23 | -13.27% since 10/26/23 | +14.14% since 05/20/19 |
| Low | 10.63 on 10/30/23 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 189.44 on 04/19/24 | 89.08 on 07/23/19 |
| High | 19.87 on 02/16/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 268.30 on 01/03/24 | 110.70 on 11/13/19 |
| Key Statistics | |||||
| Market Capitalization, $K | 324,134 | 144,488,960 | 81,266,176 | 29,429,788 | 77,035,920 |
| Shares Outstanding, K | 23,454 | 536,376 | 1,245,077 | 145,361 | 711,714 |
| Annual Sales | 82,710,000 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
| Annual Net Income | -102,240,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
| Last Quarter Sales | 23,530,000 | 8,196,000,000 | 7,114,000,000 | 2,386,300,000 | 4,520,000,000 |
| Last Quarter Net Income | -26,020,000 | 767,000,000 | 1,429,000,000 | 249,700,000 | 1,691,000,000 |
| 60-Month Beta | 1.07 | 0.58 | 0.19 | -0.02 | 1.41 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.72 on 03/14/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 3.67 on 04/24/24 | 2.99 on 10/31/19 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 04/25/24 | 04/24/24 | 10/31/19 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.64 | 9.98 | 13.47 | 10.99 |